Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation by Michael D. Green

Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation

Michael D. Green

384 pages missing pub info (editions)

nonfiction health medium-paced
Powered by AI (Beta)
Loading...

Description

Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, join...

Read more

Community Reviews

Loading...

Content Warnings

Loading...